http://www.medicalnewstoday.com/articles/183703.php
"Avid and Cardinal Health today announced that more than 100 clinical centers and more than 700 patients have now participated in a Phase III clinical trial that is testing whether Avid's molecular imaging agent Florbetapir F 18 can detect Alzheimer's disease in living patients. Florbetapir F 18 (also known as 18F AV-45 and Florbetapir) is used with positron emission tomography (PET) technology to detect beta-amyloid plaque deposits in the brain."
Wish them success.
another new early alzheimers test in ph3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $17.43K | 5.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 74 | 107941696 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1179951 | 2 |
View Market Depth
| Last trade - 15.31pm 07/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |